Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Medicine (Baltimore) ; 93(17): 290-297, 2014 Oct.
Article de Anglais | MEDLINE | ID: mdl-25398064

RÉSUMÉ

Exposure to levamisole-adulterated cocaine can induce a distinct clinical syndrome characterized by retiform purpura and/or agranulocytosis accompanied by an unusual constellation of serologic abnormalities including antiphospholipid antibodies, lupus anticoagulants, and very high titers of antineutrophil cytoplasmic antibodies. Two recent case reports suggest that levamisole-adulterated cocaine may also lead to renal disease in the form of pauci-immune glomerulonephritis. To explore this possibility, we reviewed cases of pauci-immune glomerulonephritis between 2010 and 2012 at an inner city safety net hospital where the prevalence of levamisole in the cocaine supply is known to be high. We identified 3 female patients and 1 male patient who had biopsy-proven pauci-immune glomerulonephritis, used cocaine, and had serologic abnormalities characteristic of levamisole-induced autoimmunity. Each also had some other form of clinical disease known to be associated with levamisole, either neutropenia or cutaneous manifestations. One patient had diffuse alveolar hemorrhage. Three of the 4 patients were treated with short courses of prednisone and cyclophosphamide, 2 of whom experienced stable long-term improvement in their renal function despite ongoing cocaine use. The remaining 2 patients developed end-stage renal disease and became dialysis-dependent. This report supports emerging concern of more wide spread organ toxicity associated with the use of levamisole-adulterated cocaine.


Sujet(s)
Troubles liés à la cocaïne/complications , Cocaïne/intoxication , Contamination de médicament , Glomérulonéphrite/induit chimiquement , Lévamisole/intoxication , Adulte , Femelle , Glomérulonéphrite/immunologie , Humains , Mâle , Adulte d'âge moyen
2.
J Immunol ; 171(7): 3668-74, 2003 Oct 01.
Article de Anglais | MEDLINE | ID: mdl-14500664

RÉSUMÉ

The gastroenteritis-causing pathogen Salmonella typhimurium induces profound transcriptional changes in intestinal epithelia resulting in the recruitment of neutrophils whose presence is the histopathologic hallmark of salmonellosis. Here we used cDNA microarray expression profiling to define the molecular determinants that mediate such changes in model intestinal epithelia. Enteropathogenic Salmonella induced a classical proinflammatory gene expression program similar to that activated by the canonical proinflammatory agonist TNF-alpha. Nonproinflammatory bacteria, both commensals (Escherichia coli) and systemic pathogens (S. typhi), did not activate this expression profile. While S. typhimurium strains lacking the SPI-1-encoded type III system were fully proinflammatory, strains lacking the genes for the flagellar structural component flagellin were nearly devoid of proinflammatory signaling. Lastly, the epithelial proinflammatory response could be largely recapitulated by basolateral addition of purified flagellin. Thus, S. typhimurium flagellin is the major molecular trigger by which this pathogen activates gut epithelial proinflammatory gene expression.


Sujet(s)
Entérocolite/immunologie , Entérocolite/microbiologie , Flagelline/immunologie , Muqueuse intestinale/anatomopathologie , Salmonelloses/immunologie , Salmonelloses/microbiologie , Salmonella typhimurium/immunologie , Salmonella typhimurium/pathogénicité , Lignée cellulaire , Entérocolite/anatomopathologie , Activation enzymatique/immunologie , Flagelline/génétique , Analyse de profil d'expression de gènes , Régulation de l'expression des gènes bactériens/immunologie , Humains , Muqueuse intestinale/immunologie , Muqueuse intestinale/métabolisme , Muqueuse intestinale/microbiologie , Mitogen-Activated Protein Kinases/métabolisme , Mutation , Séquençage par oligonucléotides en batterie , Salmonelloses/anatomopathologie , Salmonella typhimurium/génétique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...